Replies to post #375170 on NorthWest Biotherapeutics Inc (NWBO)

[anders2211]

well I am disagreeing with you on that, next to a big fine this could be of consequence as well and this consequence is from January 2018 so fairly recently

Failure to report the results of a clinical trial can distort the evidence base for clinical practice, breaches researchers' ethical obligations to participants, and represents an important source of research waste. The Food and Drug Administration Amendments Act (FDAAA) of 2007 now requires sponsors of applicable trials to report their results directly onto ClinicalTrials.gov within 1 year of completion. The first trials covered by the Final Rule of this act became due to report results in January, 2018. In this cohort study, we set out to assess compliance

so its not so much NWBO who might not give a dam but Dr linda liau's reputation is at stake here as well

Also why are we measuring this if NWBO Dr Liau can get away with breaching rules and or laws yes or no?